Answers are grounded in this paper and cite their sources.
Clinical trial finds mini-trackers enhance treatment monitoring by suppressing irrelevant artifacts.
Clinically irrelevant changes were shown to potentially impede carbon-ion treatment monitoring by tracking of charged nuclear fragments. However, positioning several mini-trackers around the patient, which monitor the treatment from different perspectives, was found to be the key to the identification and suppression of artifacts from anatomical changes outside of the region accessed by carbon-ion beams. This is implemented in the detection system of an ongoing clinical trial.
No takes yet. Share an insight, caveat, or question.
Kirchgässner et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: